Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs MasterCard Inc (MA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs MasterCard Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.19 (market cap $4.03B), while MasterCard Inc trades at $614.11 (market cap $528.44B). The key difference: MasterCard Inc is far larger — about 131.1× Indivior Pharmaceuticals Inc. Common Stock's market cap, and MasterCard Inc pays a 0.58% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and MasterCard Inc for 135 Days on average.
| INDV | MA | |
|---|---|---|
Market Cap | $4.03B | $528.44B |
Volume | 2,781,171 | 3,240,513 |
Sector | Health | Financials |
52-Week High | $41.83 | $604.80 |
52-Week Low | $24.09 | $471.55 |
Typical Hold Time | 0 Days | 135 Days |
Enterprise Value | $4.32B | $541.48B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Mastercard (MA) trades at $604.80, up 1.63% today, showing strong momentum near its all-time highs. The stock maintains bullish technical signals with robust fundamentals including 46.3% net income margins and consistent earnings beats. Recent institutional buying activity and overwhelmingly positive analyst sentiment (80% buy ratings) support the upward trend. The company continues to expand its digital payments leadership with strategic AI initiatives and global financial inclusion programs.
Mastercard presents a compelling growth opportunity with strong profitability and market positioning, though elevated valuation multiples warrant monitoring. Key risks include payment industry disruption from stablecoins and increasing competition. With a consensus price target of $668.67 representing 10.6% upside, the stock remains well-positioned for long-term investors despite near-term overbought technical conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →
